Proposed Data Collections Submitted for Public Comment and Recommendations, 66532-66533 [E6-19262]

Download as PDF 66532 Federal Register / Vol. 71, No. 220 / Wednesday, November 15, 2006 / Notices Dated: November 8, 2006. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E6–19260 Filed 11–14–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day-07–0469] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. Proposed Project National Program of Cancer Registries—Cancer Surveillance System—Extension (OMB number 0920–0469)-National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The American Cancer Society estimated that about 1.37 million Americans were newly diagnosed with cancer in 2005 and that about 570,000 died from cancer in that same year. The National Institutes of Health estimates that in 2005, the cost of cancer was about $209 billion, including $74 billion direct costs to treat cancer, and $136 billion indirect costs in lost productivity due to illness and premature death. In 2002, CDC implemented the National Program of Cancer Registries (NPCR)—Cancer Surveillance System (CSS) to collect, evaluate and disseminate cancer incidence data collected by population-based cancer registries. In 2002, CDC began annually publishing United States Cancer Statistics (USCS). The latest USCS report published in 2005 provided cancer statistics for 93% of the United States population from all cancer registries whose data met national data standards. Prior to the publication of USCS, at the national level, cancer incidence data were available for only 14% of the population of the United States. With this expanded coverage of the U.S. population, it will now be possible to better describe geographic variation in cancer incidence throughout the country and provide incidence data on minority populations and rare cancers to further plan and evaluate state and national cancer control and prevention efforts. Therefore, CDC’s Division of Cancer Prevention and Control proposes to continue to aggregate existing cancer incidence data from states funded by the National Program of Cancer Registries into a national surveillance system. These data are already collected and aggregated at the state level, thus, the additional burden for the states is small. Funded states are asked to continue to report cancer incidence data to CDC on an annual basis. Each state is requested to report a cumulative file containing incidence data from the first diagnosis year for which the cancer registry collected data with the assistance of NPCR funds (e.g., 1995) through 12 months past the close of the most recent diagnosis year (e.g., 2004). NCCDPHP is requesting a 3 year clearance for this project. The total number of eligible respondents is 63 which includes 50 States, 12 territories, and the District of Columbia. The total estimated annualized burden hours are 126 (i.e., 2 hours per respondent). There are no costs to the respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Respondents Number of respondents Number of responses per respondent Average burden per response (in hours) States, Territories, and the District of Columbia (Cancer Registries) ......................................... 63 1 2 Dated: November 8, 2006. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E6–19261 Filed 11–14–06; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention rmajette on PROD1PC67 with NOTICES1 [60Day–07–06BV] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the VerDate Aug<31>2005 17:21 Nov 14, 2006 Jkt 211001 Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–5960 and send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an e-mail to omb@cdc.gov. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project Travel-Related Infectious Diseases Risk Perception, Prevention Measures, and Behaviors during Travel to Latin America Visiting Friends and Relatives (VFR) versus non-VFR Travelers— New—National Center for Infectious E:\FR\FM\15NON1.SGM 15NON1 Federal Register / Vol. 71, No. 220 / Wednesday, November 15, 2006 / Notices Diseases (NCID)—Centers for Disease Control and Prevention (CDC). Background and Brief Description The proposed project will focus on travelers visiting friends and relatives (VFR) in Latin America. An estimated 44% of all international travel is VFR related. Although multiple definitions exist, VFR travelers typically refer to those who were born in a resource-poor country, now living in a resource-rich country, and returning to their country of birth to visit friends and relatives. VFR travelers have received particular attention recently for being at higher risk than other travel groups for acquiring communicable diseases during visit to their home countries. However, there are few studies that 66533 theory-driven infectious diseases prevention messages, both pre-travel and during travel, that will be specific to subpopulations of travelers (VFR versus non-VFR). Expected outcomes of targeted messaging include reducing • The burden of illness among travelers, • the importation of communicable diseases into the U.S., and • the global spread of infectious diseases. The proposed study will provide departing airport passengers with a selfadministered 35-item questionnaire and a follow-up telephone questionnaire four weeks after their return. There is no cost to the respondent other than their time. characterize and explore this health disparity between VFR and non-VFR travelers. The proposed study would be the first to focus on travel-related health risks in U.S resident VFR and non-VFR travelers to Latin America. The study objectives are to characterize and understand the health disparities between VFR and non-VFR travelers to Latin America by comparing (1) pre-travel health preparations, (2) perceived susceptibility and severity to travelrelated communicable diseases, (3) health-risk behaviors during travel, and (4) compliance with prevention measures during travel. Knowledge gained from this study will enable CDC to develop targeted, ESTIMATED ANNUALIZED BURDEN HOURS Number of responses/ respondent Number of respondents Respondents Average burden/response (in hours) Total burden hours Screener Interview ........................................................................................... Self-Administered ............................................................................................. Telephone Interview ........................................................................................ 2800 700 490 1 1 1 5/60 15/60 10/60 233 175 82 Total .......................................................................................................... ........................ ........................ ........................ 490 Dated: November 8, 2006. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E6–19262 Filed 11–14–06; 8:45 am] comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. BILLING CODE 4163–18–P Proposed Project National Disease Surveillance Program I—Case Reports—Revision— (OMB No. 0920–0009), National Center for Infectious Diseases (NCID), Centers for Disease Control and Prevention (CDC). DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–07–0009] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written Tularemia, Typhoid Fever, and Viral Hepatitis. Tularemia and MethicillinResistant Staphylococcus aureaus (MRSA) are new additions to this submission. Case report forms from state and territorial health departments enable CDC to collect demographic, clinical, and laboratory characteristics of cases of these diseases. This information is used to direct epidemiologic investigations, identify and monitor trends in reemerging infectious diseases or emerging modes of transmission, to search for possible causes or sources of the diseases, and develop guidelines for prevention and treatment. The data collected will also be used to recommend target areas most in need of vaccinations for selected diseases and to determine development of drug resistance. Because of the distinct nature of each of the diseases, the number of cases reported annually is different for each. There is no cost to respondents other than their time. The total annual burden hours are 13,371. Background and Brief Description Formal surveillance of 19 separate reportable diseases has been ongoing to meet the public demand and scientific interest in accurate, consistent, epidemiologic data. These ongoing disease reports include: Active Bacterial Core Surveillance (ABCs), CreutzfeldtJakob Disease(CJD), Cyclospora, Dengue, Hantavirus, Idiopathic CD4+Tlymphocytopenia, Kawasaki Syndrome, Legionellosis, Lyme disease, Malaria, Plague, Q Fever, Reye Syndrome, Tickborne Rickettsial Disease, Trichinosis, rmajette on PROD1PC67 with NOTICES1 ESTIMATE OF ANNUALIZED BURDEN HOURS Number of respondents Form ABCs .............................................................................................................. ABCs Invasive MRSA .................................................................................... VerDate Aug<31>2005 15:00 Nov 14, 2006 Jkt 211001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 329 18 Number responses/ respondent 21 256 E:\FR\FM\15NON1.SGM 15NON1 Total responses 6,909 4,608 Hrs/response 10/60 10/60

Agencies

[Federal Register Volume 71, Number 220 (Wednesday, November 15, 2006)]
[Notices]
[Pages 66532-66533]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-19262]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-07-06BV]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 
and send comments to Seleda Perryman, CDC Assistant Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to omb@cdc.gov.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Travel-Related Infectious Diseases Risk Perception, Prevention 
Measures, and Behaviors during Travel to Latin America Visiting Friends 
and Relatives (VFR) versus non-VFR Travelers--New--National Center for 
Infectious

[[Page 66533]]

Diseases (NCID)--Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The proposed project will focus on travelers visiting friends and 
relatives (VFR) in Latin America. An estimated 44% of all international 
travel is VFR related. Although multiple definitions exist, VFR 
travelers typically refer to those who were born in a resource-poor 
country, now living in a resource-rich country, and returning to their 
country of birth to visit friends and relatives. VFR travelers have 
received particular attention recently for being at higher risk than 
other travel groups for acquiring communicable diseases during visit to 
their home countries. However, there are few studies that characterize 
and explore this health disparity between VFR and non-VFR travelers.
    The proposed study would be the first to focus on travel-related 
health risks in U.S resident VFR and non-VFR travelers to Latin 
America. The study objectives are to characterize and understand the 
health disparities between VFR and non-VFR travelers to Latin America 
by comparing (1) pre-travel health preparations, (2) perceived 
susceptibility and severity to travel-related communicable diseases, 
(3) health-risk behaviors during travel, and (4) compliance with 
prevention measures during travel.
    Knowledge gained from this study will enable CDC to develop 
targeted, theory-driven infectious diseases prevention messages, both 
pre-travel and during travel, that will be specific to subpopulations 
of travelers (VFR versus non-VFR). Expected outcomes of targeted 
messaging include reducing
     The burden of illness among travelers,
     the importation of communicable diseases into the U.S., 
and
     the global spread of infectious diseases.
    The proposed study will provide departing airport passengers with a 
self-administered 35-item questionnaire and a follow-up telephone 
questionnaire four weeks after their return. There is no cost to the 
respondent other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden/
                   Respondents                       Number of      responses/     response (in    Total burden
                                                    respondents     respondent        hours)           hours
----------------------------------------------------------------------------------------------------------------
Screener Interview..............................            2800               1            5/60             233
Self-Administered...............................             700               1           15/60             175
Telephone Interview.............................             490               1           10/60              82
                                                 ---------------------------------------------------------------
    Total.......................................  ..............  ..............  ..............             490
----------------------------------------------------------------------------------------------------------------


    Dated: November 8, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E6-19262 Filed 11-14-06; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.